2020 Poster Titles

Room: Hall B

Presenting Monday through Wednesday

Poster Presenters noted with * are Student Fellows.

AbbVie, Inc.
1.         Deep Learning Applications in Advancing Drug Development; Presented by Liuqing Y.
Academia Sinica
2.         Integrated Devices for Rare Cell Isolation and Sensing; Presented by Peilin C.
Academia Sinica
3.         A Panel of Anti-Influenza Virus Nucleoprotein Antibodies Selected from Phage-Displayed Synthetic Antibody Libraries with Rapid Diagnostic Capability to Distinguish Diverse Influenza Virus Subtypes; Presented by An-Suei Y.
AligND Systems AB
4.         Enhanced Fluorescence Detection of Proteins Using Nanowires; Presented by Søren E.
AligND Systems AB
5.         Fluorescence Signal Enhancement Using Lightguiding Nanowires for Biosensing Applications; Presented by Søren E.
Amgen, Inc.
6.         Integrated Tool Suite for Biologics Design Enables High-Throughput Drug Discovery; Presented by Michelle H.
Amgen, Inc.
7.         Development of Informatics Pipeline for Screening Analysis via High Throughput Affinity Mass Spectrometry; Presented by Dylan O.
AmpTec GmbH
8.         Synthetic mRNAs in Multiple Clinical Trials: AmpTec as Manufacturer of High Quality GMP-Grade Synthetic mRNAs; Presented by Guido K.
AMS Biotechnology (Europe) Ltd.
9.         ONCO-Chip3D Technology: A Microfluidic Platform for Physiologically Relevant Drug Screening and Precision Medicine; Presented by Alexander S.
Aspen Biosciences
10.       The Secret Names of Things: Using Metadata to Improve Pharmaceutical Collaboration; Presented by Mark F.
Avacta Life Sciences
11.       Turning a Negative to a Positive with Anti-Metatype Affimer® Reagents; Presented by Matt J.
Aventior, Inc.
12.       Unstructured Data Extraction and Metadata Management Using AI Based Tools - DRIP and CPV; Presented by Abhijit R.
Aventior, Inc.
13.       Digital Pathology: Label Extraction Using AI; Presented by Abhijit R.
BioIVT
14.       BioIVT Triple Format (FFPE/FF, CNB/FNA) Specimen Collection for Diagnostic Assay Development; Presented by Lauren M.
BioIVT
15.       Metrics for Assessing Biospecimen Selection and Processing for Successful NGS Outcomes; Presented by Tracey Z.
Bioneer Corporation
16.       High-Throughput Cell-Free DNA Extraction System for Biopsy; Presented by Yeaseong H.
Bristol-Myers Squibb Company
17.       Biomarker 360: Empowering Knowledge and Data Driven Biomarker Decision Making to Drive Translational Medicine; Presented by Christopher W.
Broad Institute of MIT and Harvard
18.       Development of Multiplexed CRISPR-Based Diagnostics for Tick-Borne Disease; Presented by Jon A.*
Centre Hospitalier Andrée Rosemon
19.       Implementation of POCT in Public Health Centers in French Guiana; Presented by Alexandra M.
Claret Bioscience LLC
20.       SRSLY™: An Efficient, Single-Strand Ligation-Based Approach for NGS Library Preparation from Highly Fragmented DNA; Presented by Varsha R.
Creatv MicroTech, Inc.
21.       Circulating Stromal Cells and Cell Free DNA Increases Sensitivity in Profiling Oncogenic Mutations While Indicating Highly Aggressive Non-Small Cell Lung Cancer; Presented by Daniel A.
Creatv MicroTech, Inc.
22.       Training and Validation for Sequential Monitoring of Circulating Stromal Cells for Predicting Progression in NSCLC Cancer Patients Undergoing Definitive Radiotherapy; Presented by Daniel A.
DiaCarta, Inc.
23.       XNA-Based OptiSeq Dual Cancer Panel, a Highly Sensitive and Reproducible Method for Early Detection of Cancer; Presented by Zhen C.
DiaCarta, Inc.
24.       A Highly Sensitive and User-Friendly Assay for BRAF V600 Mutation Detection; Presented by Yulei S.
DiaCarta, Inc.
25.       A Novel XNA-Based Multiplex qPCR Panel Assay for Colorectal Cancer Mutation Detection; Presented by Qing S.
Duke University
26.       A Low-Cost Point of Care Diagnostic Fluorescent Microarray Scanner; Presented by Jason L.*
Duke University
27.       Detecting the Decoy: D4 Immunoassay Targeting Ebola's Secreted Glycoprotein Yields Earlier than PCR Detection of Infection; Presented by Cassio F.*
Duke University
28.       Cellular and Molecular Credentialing of Breast Tumor HER2 Status Using a Cell Phone; Presented by Jacob H.*
Duke University
29.       A Portable Point-of-Care Platform for Rapid Diagnosis and Screening of Fungal Talaromycosis Infection; Presented by David K.*
Duke University
30.       Point-of-Care Plasmonically Enhanced Immunoassay for Early Detection of Heart Failure; Presented by Daria S.*
Food and Drug Administration
31.       In Vitro Modeling of Circulating Tumor Cells Towards Novel Cancer Biomarkers; Presented by Julianne T.
Forschungszentrum Jülich
32.       Small-Molecule Modulators of TRMT2a Decrease PolyQ Aggregation and PolyQ-Induced Cell Death; Presented by Michael M.*
Hitachi High Technologies America, Inc.
33.       Virtual Screening to Discover Probable Compounds' Spaces Based on Mixture of Mutated Exemplars and Bioassay Existence Ratio; Presented by Takashi I.
Horizon Discovery
34.       A Comparison of Different Formats of DNA Reference Standards Commutable with Solid and Liquid Biopsy Samples for Cancer Genomic Profiling; Presented by Jesse S.
Horizon Discovery
35.       Development of cfDNA Reference Standards that Are Compatible with Commonly Used Extraction Methods and Molecular Assays; Presented by Julie W.
immunoSCAPE
36.       Immuno-Phenotyping of Tumor-Specific CD8 T Cells Using High-Dimensional Mass Cytometry; Presented by Brian A.
IQVIA
37.       Impact of Tumour Genomic Characteristics on Healthcare Resource Utilisation and Real-World Outcomes in Patients with Non-Small Cell Lung Cancer: A Real World Study Using Linked Whole Genome-Clinical Databases; Presented by Mike G.
Johns Hopkins University
38.       Bisulfite-Converted Duplexes for the Strand-Specific Detection and Quantification of Rare Mutations; Presented by Austin M.*
Keen Eye Technologies
39.       Diagnosing and Subtyping Lung Cancer Using Deep Learning on Whole Slide Images; Presented by Sylvain B.
Koo Foundation Sun-Yat Sen Cancer Center
40.       Circulating Tumor DNA as a Prognostic Biomarker in Metastatic Breast Cancer; Presented by Yong W.
Korea Institute of Machinery and Materials
41.       Microfluidic Condensation Sampler for Collection of Nanoscale Airborne Particles; Presented by Kwanoh K.
LCM Biosensor Technologies
42.       Monitoring Osmotic Pressure of Intercellular Substance in Prevention of Chronic Disease; Presented by Ramil M.
miDiagnostics
43.       The World's Most Compact Complete Blood Count Prototype Ever Built; Presented by Christopher A.
NanoView Biosciences
44.       Exosome Biomarkers: Multiparametric Characterization and Phenotypic Analysis; Presented by Clayton D.
National University of Singapore
45.       Companion Diagnostics for Trastuzumab-Based Neoadjuvant Therapy - Two Is Better than One; Presented by Yoon Pin L.
New York Genome Center
46.       GenomeDiver - Keeping the Human in the Loop; Presented by Christian S.
Nottingham Trent University
47.       The Design and Development of Electronic Textiles for Health Monitoring Applications; Presented by Theodore H.
NVIGEN, Inc.
48.       Comparative Study of Matrix Effects and Extraction Methods on Assay Sensitivity Validation Samples Contrived with Human Plasma; Presented by Aihua F.
NVIGEN, Inc.
49.       Achieving State-of-the-Art Nucleic-Acid Detection Accuracy in qPCR with Help of Deep Convolutional Machines Learning Neural Networks; Presented by Aihua F.
NVIGEN, Inc.
50.       High Yield Cell Free DNA Capture and Diagnositics with Molecularly Engineered Magnetic Nanoparticles; Presented by Aihua F.
RareCyte, Inc.
51.       Validation of an Assay to Detect Programmed Death-Ligand 1 (PD-L1) Expression on Circulating Tumor Cells; Presented by Adrian Q.
RealSeq Biosciences, Inc.
52.       Highly Sensitive Direct Quantification of cf-microRNAs for Biomarker Profiling by Next Generation Sequencing (NGS); Presented by Sergio B.
Sandia National Laboratories
53.       Thermodynamic Predictions of Primer Interactions and Impact on LAMP Assay Performance; Presented by Robert M.
Schrödinger
54.       An Automated Workflow to Identify Suitable Targets for Physics-Based Drug Discovery; Presented by Felicia G.
Seegene, Inc.
55.       Analytical Performance and Workflow Comparisons of Seegene's Automation Platforms; Presented by Mira K.
Seegene, Inc.
56.       The Development of Cloud-Based Statistical Software for Monitoring Results of Multiplex Syndromic Assays; Presented by Eugene K.
Sookmyung Women’s University
57.       Target Prediction and Validation of Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor; Presented by Yoon-Jung K.*
Sookmyung Women’s University
58.       Network-Based Drug Repositioning Approaches of Phenoxazine-Linked Thiourea Analogues for Prevention of Osteoclastogenesis; Presented by Eun L.*
St. Jude Children's Research Hospital
59.       Using mHealth Apps to Improve Care for Patients with Sickle Cell Disease: Design of the mHealth Embedded in the Care of Sickle Cell Patients Who Take Hydroxyurea (mESH) Trial; Presented by Jane H.
Stanford University
60.       A Magnetoresistive Biosensor Assay for Detecting Circulating Tumor DNA in Non-Small Cell Lung Cancer; Presented by Katie A.*
Thermo Fisher Scientific
61.       Development of an Expanded Microsatellite Instability Panel with Automated Data Analysis; Presented by Charles B.
Thermo Fisher Scientific
62.       Specific Capture of Nucleic Acids for Molecular Diagnostics and mRNA-Based Therapeutics Applications Using Dynabeads™; Presented by Laure J.
Thermo Fisher Scientific
63.       Next Generation DNase for Ultimate Performance in Therapeutic, IVD and Molecular Biology Applications; Presented by Samantha L.
Thermo Fisher Scientific
64.       Single-Use Based BioProduction Process for Manufacturing of High Quality Recombinant Enzymes for mRNA and DNA Workflows; Presented by Samantha L.
Thermo Fisher Scientific
65.       A High-Throughput Approach for Multi-Omic Testing for Prostate Cancer Research; Presented by Christopher T.
Tohoku University
66.       Development of Ingestible Sensor Platform Based on Gastric Acid Battery; Presented by Shinya Y.
University of Chicago
67.       Using Indication Embeddings to Represent Patient Health for Drug Safety Studies; Presented by Rachel M.
University of Georgia
68.       Tumor Antigen-Independent and Cell Size Variation-Inclusive Enrichment of Viable Circulating Tumor Cells; Presented by Yang L.*
Vortex Biosciences, Inc.
69.       An Integrated Workflow for the Automated Isolation, High Throughput Identification, Enumeration and Characterization of Circulating Tumor Cells; Presented by Corinne R.
Wainamics, Inc.
70.       Critical Components for Lab-on-a-Chip Product Development; Presented by Ming T.
X Gen US Co.
71.       Novel Transposase Accelerates Liquid Biopsy Tests for cfDNA, cfRNA and CTCs; Presented by Andreas T.